entinostat and tubacin
entinostat has been researched along with tubacin in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bradner, JE; Grachan, ML; Greenberg, EF; Haggarty, SJ; Mazitschek, R; Warnow, T; West, N | 1 |
| Bradner, JE; Estiu, G; Greenberg, E; Mazitschek, R; West, N; Wiest, O | 1 |
| Choi, SE; Pflum, MK; Weerasinghe, SV | 1 |
| Feng, T; Lu, H; Su, H; Sun, H; Wang, H; You, Q; Yu, L; Zhang, X | 1 |
| Cheng, F; Dong, N; Huang, J; Jiang, X; Li, J; Lin, P; Liu, M; Lu, W; Ouyang, P; Tang, Y; Wu, D; Wu, Z; Xu, Z; Yao, X; Zeng, M; Zhang, C; Zou, S | 1 |
| Brindisi, M; Brogi, S; Butini, S; Campiani, G; Gemma, S; Saraswati, AP | 1 |
| Alfano, AI; Barone, S; Brindisi, M; Cassese, E; Summa, V | 1 |
| Ng, YK; Ong, WY; Tan, CS | 1 |
Reviews
1 review(s) available for entinostat and tubacin
| Article | Year |
|---|---|
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.
Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Histone Deacetylase 6; Humans; Signal Transduction | 2022 |
Other Studies
7 other study(ies) available for entinostat and tubacin
| Article | Year |
|---|---|
Chemical phylogenetics of histone deacetylases.
Topics: | 2010 |
On the inhibition of histone deacetylase 8.
Topics: Computer Simulation; Drug Design; Enzyme Inhibitors; Histone Deacetylases; Humans; Molecular Dynamics Simulation; Protein Binding; Protein Isoforms; Repressor Proteins; Substrate Specificity | 2010 |
The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C3 position display isoform selectivity.
Topics: Antineoplastic Agents; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Neoplasms; Protein Isoforms; Vorinostat | 2011 |
Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2).
Topics: Acrylamide; Binding Sites; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; HCT116 Cells; Hep G2 Cells; Histone Deacetylase 1; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Molecular Docking Simulation; Recombinant Proteins; Repressor Proteins; Structure-Activity Relationship | 2013 |
Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis.
Topics: Acute Lung Injury; Animals; Epoxide Hydrolases; Female; Histone Deacetylase Inhibitors; Idiopathic Pulmonary Fibrosis; Leukotriene B4; Mice; Mice, Inbred C57BL; Neutrophils | 2017 |
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.
Topics: Animals; Biomarkers; Cell Line; Epigenesis, Genetic; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Mice; Protein Processing, Post-Translational; Rare Diseases | 2020 |
Epigenetic Regulation of Cytosolic Phospholipase A2 in SH-SY5Y Human Neuroblastoma Cells.
Topics: Anacardic Acids; Anilides; Benzamides; Cell Line, Tumor; Chromatin Immunoprecipitation; Deoxyadenosines; Epigenesis, Genetic; Fluorescent Antibody Technique; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Group IV Phospholipases A2; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; L-Lactate Dehydrogenase; Lysine; Neuroblastoma; Pyridines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Thiazoles; Thionucleosides; Valproic Acid | 2016 |